DanCann Pharma A/S: CEO, Jeppe Krog Rasmussen (Xignotus Capital ApS), locks his position in DanCann Pharma for 3 years - and thereby more than 21% of the total share capital
COPENHAGEN, Denmark, 17 December 2021 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the “Company”), a Danish company powered by cannabinoids, hereby announce that the CEO of DanCann Pharma, Jeppe Krog Rasmussen (indirectly through his holding company: Xignotus Capital ApS (“Jeppe Krog Rasmussen” or “Xignotus Capital”)), has chosen to lock his position in talks with the Board of Directors of DanCann Pharma in an Agreement (the "Agreement") which locks Jeppe Krog Rasmussen's position in the company for another 36 months, under the Agreement and agreed Conditions (the “Conditions”),